About: NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $22.79 (-11.08%)
NAMSNASDAQNewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Company N.V. Ordinary Shares share price
NAMS price activity
Last Price
$22.790
Change (24hr)
-2.84 USD (-11.08%)
Volume
2.32M
Volume (4w avg)
-
Open
$25.35
Day Range
$22.34 - $25.53
Previous Close
$25.63
Last Trade
09 Sep, 8:17 pm GMT+0
Delayed
09 Sep, 8:17 pm GMT+0
NAMS price performance
Delayed
09 Sep, 8:17 pm GMT+0
NAMS Market Signals